A Phase II Study of Paclitaxel in Platinum Pretreated Ovarian Cancer. A Hellenic Cooperative Oncology Group Study

By Aravantinos G.   Skarlos D.V.   Kosmidis P.   Athanassiades A.   Bafaloukos D.   Giannakakis T.   Karpathios S.   Fountzilas G.  

European Journal of Cancer, Vol. 33, Iss. 1, 1997-01 ,pp. : 160-163

Elsevier

Access to resources Recommend Favorite

Paclitaxel by 3-h Infusion and Carboplatin in Anthracycline-resistant Advanced Breast Cancer. A Phase II Study Conducted by the Hellenic Cooperative Oncology Group

By Fountzilas G.   Athanassiadis A.   Kalogera-Fountzila A.   Aravantinos G.   Bafaloukos D.   Briasoulis E.   Dombros N.   Ioannidis I.   Pavlidis N.   Kosmidis P.   Skarlos D.  

European Journal of Cancer, Vol. 33, Iss. 11, 1997-10 ,pp. : 1893-1895

Elsevier

Access to resources Recommend Favorite

Phase II Trial of Pyrazoloacridine in Recurrent Platinum-Sensitive Ovarian Cancer: A Gynecologic Oncology Group Study

By Plaxe S.C.   Blessing J.A.   Bookman M.A.   Creasman W.T.  

Gynecologic Oncology, Vol. 84, Iss. 1, 2002-01 ,pp. : 32-35

Elsevier

Access to resources Recommend Favorite

Evaluation of Cisplatin and Cyclosporin A in Recurrent Platinum-Resistant Ovarian Cancer: A Phase II Study of the Gynecologic Oncology Group

By Manetta A.   Blessing J.A.   Hurteau J.A.  

Gynecologic Oncology, Vol. 68, Iss. 1, 1998-01 ,pp. : 45-46

Elsevier

Access to resources Recommend Favorite

Combination of Ifosfamide, Paclitaxel, and Cisplatin for the Treatment of Metastatic and Recurrent Carcinoma of the Uterine Cervix: A Phase II Study of the Hellenic Cooperative Oncology Group

By Dimopoulos M.A.   Papadimitriou C.A.   Sarris K.   Aravantinos G.   Kalofonos C.   Gika D.   Gourgoulis G.M.   Efstathiou E.   Skarlos D.   Bafaloukos D.  

Gynecologic Oncology, Vol. 85, Iss. 3, 2002-06 ,pp. : 476-482

Academic Press

Access to resources Recommend Favorite